Description
NOW IN ELEVEN EDITIONS—The Worldwide Market for Point-of-Care (POC) Diagnostic Tests forecasts the POC market through 2028.
Lab-based analyzers in hospitals and reference labs are the cornerstone of revenues in the in vitro diagnostics (IVD) industry. However, the point-of-care (POC) segment is seen as a key growth area. Point-of-care refers to tests that can provide meaningful results during a provider visit or in the patient’s home.
Over the past two decades, Kalorama Information has observed that POC tests present significant opportunities for expansion. This rich history analyzing the market is at the forefront of The Worldwide Market for Point-of-Care (POC) Diagnostic Tests, the eleventh edition in Kalorama’s POC report series.
The role of diagnostics in promoting wellness, improving patient-provider encounters, aiding in drug selection and stewardship, facilitating home or nursing home care, and ensuring effective pandemic management relies heavily on the success of point-of-care solutions. The global POC testing market has experienced significant growth in the last two decades due to the increasing demand for accurate and rapid testing, both within and outside hospital settings. Technological advancements in smartphones, biosensors, lab-on-a-chip, and wearable devices have influenced the POC landscape, aiming to provide expedited diagnosis at the point-of-care.
As a result, point-of-care diagnostics can command higher pricing and experience larger revenue growth compared to lab-based tests. The tests covered in The Worldwide Market for Point-of-Care (POC) Diagnostic Tests tend to grow at higher rates than the overall IVD market.
Enhanced Segmentation – Many Reports in One
The report delves into various areas of POC diagnostics, including:
- Glucose
- Coagulation
- CRP
- Other Cardiac Markers
- Colon Cancer
- Pregnancy / Fertility
- Drugs of Abuse
- hbA1c
- Cholesterol
- HIV
- COVID-19
- Other Infectious Disease
- Critical Care Tests
Each area is thoroughly analyzed, providing market sizing and forecasts.
Venue Market Analysis
POC tests are conducted in various settings, including hospital departments (emergency, operating rooms, intensive care units), physicians’ offices, hospital clinics, retail clinics, pharmacies, homes (self-testing or by caregivers), and nursing homes.
POC testing may be performed by laboratory personnel, but often it is performed by non-laboratory personnel such as physicians, nurses, assistants in medical offices, emergency medical technicians (EMTs), medics, pharmacists, and the patients themselves (self-testing). Some POC tests are manual tests, often performed with technologies based on dipsticks or strips, lateral flow cassettes, or other manual tests. There are also many small, portable instruments that have been developed for use in POC settings. With the advances in miniaturization and microfluidics that have occurred in recent years, a growing number of small, handheld devices are reaching the POC market for a range of different testing applications.
Regional Coverage
POC is an international market and Kalorama reflects this with regional coverage. Analysis is anchored by:
- Europe
- Japan
- United States
- Rest of World
Other countries and regions discussed in the report include:
- Australia
- Canada
- China
- France
- Germany
- India
- Italy
- South Korea
- Spain
- Sweden
- Switzerland
- Latin America
- Middle East
Corporate Profiles
The Worldwide Market for Point-of-Care (POC) Diagnostic Tests also highlights the contribution of POC test devices to the overall diagnostics market growth. More diagnostic manufacturers are seeking CLIA waiver status or CE Mark for their POC devices, indicating the growing importance of POC testing in diagnosis and patient care monitoring. Rapid tests are also becoming more prevalent in the POC arena, allowing physicians to treat patients more effectively and efficiently.
This report breaks out point-of-care testing by segment.
Among the top and/or innovative competitors discussed within Corporate Profiles are:
- 1 Step Detect Associates
- Abbott Labs
- Abingdon Health
- Access Bio
- AccuBioTech
- ACON Laboratories
- Aerscher Diagnostics
- Alfa Scientific Designs
- American Bio Medica
- ARKRAY
- Artron Laboratories
- Ascensia Diabetes Care
- Atlas Link Biotech
- Autobio Diagnostics
- Beckman Coulter
- Becton Dickinson
- Beijing Wantai Biological Pharmaceuticals
- Bhat Bio-Tech India Private Ltd.
- Binx health
- bioLytical Laboratories
- BioMedomics
- Biomeme
- Biomerica
- bioMérieux SA
- Biophor Diagnostics
- Bio-Rad Laboratories
- Biosensia
- Biotron Diagnostics
- Boditech Med
- Boson Biotech
- BTNX
- Cepheid
- Chembio Diagnostic Systems
- Church & Dwight
- Clarity Diagnostics
- Confirm Biosciences
- CTK Biotech
- Cue Health
- Danaher Corporation
- Dexcom
- DIALAB
- DiaSys Diagnostic Systems
- Diazyme Laboratories
- DNA Electronics Ltd.
- Dr Fooke-Achterrath
- DxGen
- Eiken Chemical
- EKF Diagnostics
- ELITechGroup, Inc
- Enterix
- Eurobio Scientific
- Eurolyser Diagnostica
- Everlywell
- Exact Sciences
- EY Laboratories
- Fio Corp
- First Check Diagnostics
- GenBio
- Genedrive
- GenePOC
- GeTein BioMedical
- Helena Labs
- Hemosure
- HORIBA
- Immune IQ
- Immunosciences Lab
- Immunostics
- JAL Innovation
- Jant Pharmacal
- Mitra & Co
- Kypha
- LamdaGen Corp
- LifeScan
- LifeSign
- LightDeck Diagnostics
- LumiraDx
- Macherey-Nagel
- Medix Biochemica
- MedMira
- Medtronic
- Menarini Diagnostics
- Meridian BioScience
- MiCo BioMed
- Nano-Ditech Corporation
- Nexus Dx
- NG Biotech
- Noble Medical
- Nova Biomedical
- Oasis Diagnostics
- Operon
- OPKO Health
- OraSure Technologies
- PixCell Medical Technologies
- Polymedco
- Polymer Technologies
- Preventis
- Princeton Biomeditech
- QuantuMDx Group
- QuidelOrtho
- Radiometer Medical
- Randox Labs
- Response Biomedical
- Reszon Diagnostics
- Rheonix
- Roche Diagnostics
- Savyon Diagnostics
- Sekisui Diagnostics
- Siemens Healthcare
- Sysmex
- TECHLAB
- Teco Diagnostics
- Trinity Biotech
- Trividia Health
- Tulip Diagnostics
- VedaLab
- Werfen
Scope and Methodology
The Worldwide Market for Point-of-Care (POC) Diagnostic Tests is now in its eleventh edition, reflecting more than two decades of Kalorama’s analysis of the POC market.
The geographic scope of The Worldwide Market for Point-of-Care (POC) Diagnostic Tests is global, with information for specific geographical regions, world demographics, and other general issues affecting the market. The report’s market summary includes total market values, market analysis by product, test usage, technology, region, end-use and a competitive analysis of leading providers. Additionally, key company profiles are included.
All market data pertains to the world market at the manufacturers’ level. The market includes manufacturer tests excluding services. The base year for data was 2023. Forecast data is provided for 2023 through 2028. Compound annual growth rates (CAGRs) are provided for the 2023-2028 period for each segment covered. Competitive analysis is provided for the year 2023 along with regional breakdowns. The forecasted market analysis for 2023-2028 was largely based on demographic trends, new developments, innovative technology and global expansion.
Table of Contents
Chapter 1: Executive Summary
Introduction
Scope and Methodology
Size and Growth of the Market
- Table 1-1: Global POC Test Market, 2023-2028 (in millions $ at manufacturer level)
Trends Affecting the Market
Competitive Outlook
Market Conclusions
Conclusion One – POC market transformed by technological progress
Conclusion Two – POC Molecular Diagnostics continue making inroads
Conclusion Three – Prevention and early detection at nexus of POC development
Conclusion Four – Wearables continue to influence POC market
Conclusion Four – Test cost will continue to be an issue worldwide
Conclusion Five – Rising demand will drive POC market in RoW markets
Conclusion Six – New venues – urgent & retail care
Conclusion Seven – COVID-19’s Positive Effect
Conclusion Eight – Insurance coverage for OTC COVID-19 testing
Conclusion Nine – New Opportunities in POC Infectious Disease Testing
Conclusion Ten – Supply Chain Delays
Conclusion Eleven – Multiplex Testing Explodes
Conclusion Twelve – AI Making Inroads into POC
Conclusion Thirteen – Stand-alone ER/Urgent Centers Gain Acceptance
Conclusion Fourteen – Digital Diagnostics and POC
Conclusion Fifteen – Microfluidics Gaining Ground in POC
Chapter 2: Introduction and Overview
Point-of-Care Diagnostics Testing
Industry Regulations
Types of CLIA Certificates
POC Industry Drivers
Patient focused drivers
Medical/Healthcare related drivers
Technology drivers
Economic drivers
Other drivers
POC Industry Challenges
POC Test Types
Blood
Urine
Saliva
Hair
Optical Technologies
Breath
Conditions Evaluated by POC Diagnostic Testing
Cancer
- Colorectal Cancer
- Prostate Cancer
Cardiovascular Disease
Diabetes
Drug Abuse
Infectious Disease
- Herpes
- HTLV
- Respiratory Syncytial Virus
- Hepatitis
- Lyme Disease
- Babesiosis
- Gonorrhea, Syphilis and Chlamydia
- Trichomonas Vaginalis
- HIV/AIDS
- Helicobacter Pylori
- Influenza
- Coronavirus
- Mononucleosis
- Streptococcus
Osteoporosis
Pregnancy and Fertility
Chapter 3: POC Blood Glucose Tests
Types of Blood Glucose Testing
Fasting Blood Sugar (FBS)
2-Hour Postprandial Blood Sugar (PPBS)
Random Blood Sugar
Glucose Tolerance Test
Glucose Urine Test
Glycated Hemoglobin (HbA1c)
Products
Blood Glucose Self-Testing
- Table 3-1: Selected Glucose Self-Test Meter Innovations
- Table 3-2: Selected Apps and Glucose Management IT
Continuous Self-Testing
Glycated Hemoglobin Tests
- Table 3-3: Selected POC HbA1c Devices
Professional
Market Size and Growth
- Table 3-4: Global POC Glucose (including CGM and HbA1c) Testing Market Analysis, 2023-2028 (in millions $ at the manufacturer’s level)
- Table 3-5: Global POC Diabetes Sales, by Test Category, 2023-2028 (Glucose, Self-test; Glucose, professional; Glucose, continuous; HbA1c, POC; TOTAL; $ millions)
Regional Analysis
- Figure 3-1: POC Blood Glucose Testing Regional Market Analysis, 2023 (%)
POC Glucose Self-Testing
- Table 3-6: Global POC Glucose Self-Testing Market (excludes continuous glucose devices), 2023-2028 (in millions $ at manufacturer level)
- POC Continuous Glucose Self-Testing
- Table 3-7: Global POC Continuous Glucose Self-Testing Market, 2023-2028 (in millions $ at manufacturer level)
POC Glucose Professional Testing
- Table 3-8: Global POC Glucose Professional Testing Market (excludes HbA1c testing), 2023-2028 (in millions $ at manufacturer level)
- POC HbA1c Testing
- Table 3-9: Global POC Glucose HbA1c Professional Testing Market, 2023-2028 (in millions $ at manufacturer level)
Competitive Analysis
- Table 3-10: Global POC Blood Glucose Testing Market (BGM, CGM,HbA1c) Revenues and Market Share of Leading Suppliers, 2023 (in millions $)
- Figure 3-2: Global POC Glucose Test Manufacturers, by Percent, 2023 (%)
Chapter 4: POC Blood and Electrolytes Testing Market
Types of Blood and Electrolytes Tests
Hemoglobin/Hematocrit
WBC and Other
Blood Gases
Electrolytes
Products
- Table 4-1: Selected POC Hemoglobin and Hematocrit Systems, 2023
- Table 4-2: Selected POC Hematology Analyzer Systems, 2023
Market Size and Growth
- Table 4-3: Global POC Blood and Electrolytes Testing (Blood Gases/Electrolytes, Hemoglobin/Hematocrit, WBC), Market Analysis, 2023-2028 (in millions $ at the manufacturer’s level)
- Table 4-4: Global POC Blood & Electrolytes Revenues, by Test Category, 2023-2028 ($ millions)
Regional Analysis
- Figure 4-1: POC Blood and Electrolytes Testing Regional Market (US, Europe, Japan, Rest of World) Analysis, 2023 (%)
POC Blood and Electrolyte Self-Testing
- Table 4-5: Global POC Blood and Electrolyte Self Testing Market Analysis, 2023-2028 (in millions $ at the manufacturer’s level)
POC Blood and Electrolyte Professional Testing
- Table 4-6: Global POC Blood and Electrolyte Professional Testing Market Analysis, 2023-2028 (in millions $ at the manufacturer’s level)
Competitive Analysis
- Table 4-7: Global POC Blood and Electrolyte Testing Market, Revenues and Market Share of Leading Suppliers, 2023 (in millions $)
- Figure 4-2: Global POC Blood and Electrolyte Testing Market Manufacturers, by Percent, 2023 (%)
Chapter 5: POC Rapid Coagulation
Products
- Table 5-1: Selected POC Coagulation Test Innovations
Platelet Testing
- Table 5-2: Selected Platelet Activity Test Innovations
Market Size and Growth
- Table 5-3: Global Rapid Coagulation Testing Market Analysis, 2023-2028 (in millions $ at the manufacturer’s level)
Regional Analysis
- Figure 5-1: POC Rapid Coagulation Testing Regional (US, Europe, Japan, Rest of World) Market Analysis, 2023 (%)
POC Rapid Coagulation Self-Testing
- Table 5-4: POC Rapid Coagulation Self-Testing Market Analysis, 2023-2028 (in millions $ at the manufacturer’s level)
POC Rapid Coagulation Professional Testing
- Table 5-5: POC Rapid Coagulation Professional Testing Market Analysis, 2023-2028 (in millions $ at the manufacturer’s level)
Competitive Analysis
- Table 5-6: Global POC Rapid Coagulation Testing Market, Revenues and Market Share of Leading Suppliers, 2023 (in millions $)
- Figure 5-2: Global POC Rapid Coagulation Testing Market, Market Share of Leading Suppliers, 2023 (%)
Chapter 6: POC Rapid Cardiac Markers
Products
Market Size and Growth
- Table 6-1: Total Rapid Cardiac Markers Tests Market Analysis, 2023-2028 (in millions $ at the manufacturer’s level)
Regional Analysis
- Figure 6-1: POC Rapid Cardiac Markers Testing, Regional (US, Europe, Japan, Rest of World) Market Analysis, 2023 (%)
Competitive Analysis
- Table 6-2: Global POC Cardiac Markers Test Market, Revenues and Market Share of Leading Suppliers, 2023 (in millions $)
- Figure 6-2: Global POC Cardiac Markers Test Manufacturers, by Percent, 2023 (%)
Chapter 7: POC Substance Abuse
Overview
Products
Urine
Oral
Blood
Hair
Market Size and Growth
- Table 7-1: Global POC Drugs of Abuse Testing (critical care, employment and criminal) Market Analysis, 2023-2028 (in millions $ at the manufacturer’s level)
Regional Analysis
- Figure 7-1: POC Substance Abuse Testing Regional (US, Europe, Japan, Rest of World) Market Analysis, 2023 (%)
POC Drugs of Abuse Self-Testing
- Table 7-2: Global POC Drugs of Abuse Self Testing Market, 2023-2028 ($ millions at the manufacturer’s level)
POC Drugs of Abuse Professional Testing
- Table 7-3: Global POC Drugs of Abuse Professional Testing Market Analysis, 2023-2028 (in millions $ at the manufacturer’s level)
Competitive Analysis
- Table 7-4: Global POC Drugs of Abuse Testing Market, Revenues and Market Share of Leading Suppliers, 2023 (in millions $)
- Figure 7-2: Global POC Drug of Abuse Testing Manufacturers, by Percent, 2023 (%)
Chapter 8: POC Pregnancy and Fertility Testing
Products
- Table 8-1: Selected Pregnancy and Fertility CLIA Waivers (Manufacturer and Instrument / Assay), Manufacturer’s Instrument / Device / Assay
Market Size and Growth
- Table 8-2: Global POC Pregnancy and Fertility Testing Market Analysis, 2023-2028 (in millions $ at the manufacturer’s level)
Regional Analysis
- Figure 8-1: POC Pregnancy and Fertility Testing Regional (US, Europe, Japan, Rest of World) Market Analysis, 2023 (%)
POC Pregnancy and Fertility Self-Testing
- Table 8-3: POC Pregnancy and Fertility Self-Testing Market Analysis, 2023-2028 (in millions $ at the manufacturer’s level)
POC Pregnancy and Fertility Professional Testing
- Table 8-4: POC Pregnancy and Fertility Professional Testing Market Analysis, 2023-2028 (in millions $ at the manufacturer’s level)
Competitive Analysis
- Table 8-5: Global POC Pregnancy and Fertility Testing Market, Revenues and Market Share of Leading Suppliers, 2023 (in millions $)
- Figure 8-2 Global POC Pregnancy and Fertility Testing Manufacturers, by Percent, 2023 (%)
Chapter 9: POC Colon Cancer Screening/Fecal Occult Blood Testing
Products
- Table 9-1: Selected POC Colon Cancer Tests
Market Size and Growth
- Table 9-2: Global POC Colon Cancer Screening/Fecal Occult Blood Testing Market Analysis, 2023-2028 (in millions $ at the manufacturer’s level)
Regional Analysis
- Figure 9-1: POC Colon Cancer Screening/FOB Testing Regional (US, Europe, Japan, Rest of World) Market Analysis, 2023 (%)
POC Colon Cancer Screening/Fecal Occult Blood Self-Testing
- Table 9-3: POC Colon Cancer Screening/Fecal Occult Blood Self-Testing Market Analysis, 2023-2028 (in millions $ at the manufacturer’s level)
POC Colon Cancer Screening/ Fecal Occult Blood Professional Testing
- Table 9-4: POC Colon Cancer Screening/Fecal Occult Blood Professional Testing Market Analysis, 2023-2028 (in millions $ at the manufacturer’s level)
Competitive Analysis
- Table 9-5: Global POC Colon Cancer Screening/Fecal Occult Blood Testing Market, Revenues and Market Share of Leading Suppliers, 2023 (in millions $)
- Figure 9-2: Global POC Colon Cancer Screening/Fecal Occult Blood Testing Manufacturers, by Percent, 2023 (%)
Chapter 10: POC Infectious Disease Testing
Products
HIV and Hepatitis
Respiratory
STD/STI
Tropical Diseases
Lyme Disease
TB
Zika
Anthrax
Other Viruses
Hospital Acquired Infections and Sepsis
- Sepsis
- Diff
- Table 10-1: Selected Innovations in POC Infectious Disease Diagnostics
COVID-19
- Antigen
- Table 10-2: Selected Antigen POC Home Immunoassay Tests for SARS-CoV-2
- Serology
- Molecular
- Table 10-3: Selected Molecular POC Home Tests for SARS-CoV-2
Market Size and Growth
- Table 10-4: Global POC Infectious Disease (including COVID-19) Testing Market Analysis, 2023-2028 (in millions $ at the manufacturer’s level)
Regional Analysis
- Figure 10-1: POC Infectious Disease (including COVID-19) Testing Regional (US, Europe, Japan, Rest of World) Market Analysis, 2023 (%)
POC Infectious Disease Self-Testing
- Table 10-5: POC Infectious Disease Self-Testing (including COVID-19) Market Analysis, 2023-2028 (in millions $ at the manufacturer’s level)
POC Infectious Disease Professional Testing
- Table 10-6: POC Infectious Disease (including COVID-19) Professional Testing Market Analysis, 2023-2028 (in millions $ at the manufacturer’s level)
POC Infectious Disease Testing by Disease Type
- Table 10-7: Global POC Infectious Disease Revenues and Percent of Infectious Disease Market, by Disease Type, 2023 (in millions $)
- Figure 10-2: Global POC Infectious Disease (COVID-19, Influenza, HIV, STD, Hepatitis, Malaria, C. Diff, coli, H. pylori, Home, Others), Percent by Disease Type, 2023 (%)
Competitive Analysis
- Table 10-8: Global POC Infectious Disease including COVID-19 Testing Market, Revenues and Market Share of Leading Suppliers, 2023 (in millions $)
- Figure 10-3: Global POC Infectious Disease Test Manufacturers, by Percent, 2023 (%)
Chapter 11: POC Lipid Testing
Products
Market Size and Growth
- Table 11-1: Global POC Lipid Testing Market Analysis, 2023-2028 (in millions $ at the manufacturer’s level)
Regional Analysis
- Figure 11-1: POC Lipid Testing Regional (US, Europe, Japan, Rest of World) Market Analysis, 2023 (%)
POC Lipid Self-Testing
- Table 11-2: POC Lipid Self-Testing Market Analysis, 2023-2028 (in millions $ at the manufacturer’s level)
POC Lipid Professional Testing
- Table 11-3: POC Lipid Professional Testing Market Analysis, 2023-2028 (in millions $ at the manufacturer’s level)
Competitive Analysis
- Table 11-4: Global POC Lipid Testing Market, Revenues and Market Share of Leading Suppliers, 2023 (in millions $)
- Figure 11-2: Global POC Lipid Testing Manufacturers, by Percent, 2023 (%)
Chapter 12: POC Cancer Tumor Marker Testing
Products
- Table 12-1: Selected Companies Developing and/or Marketing POC Tests for Oncology Indications
Market Size and Growth
- Table 12-2: Global POC Cancer Testing Market Analysis, 2023-2028 (in millions $ at the manufacturer’s level)
Regional Analysis
- Figure 12-1: POC Cancer Tumor Marker Testing Regional (US, Europe, Japan, Rest of World) Market Analysis, 2023 (%)
Competitive Analysis
- Table 12-3: Global POC Cancer Testing Market, Revenues and Market Share of Leading Suppliers, 2023 (in millions $)
- Figure 12-2: Global POC Cancer Testing Manufacturers, by Percent, 2023 (%)
Chapter 13: POC Urine Testing
Products
Market Size and Growth
- Table 13-1: Global POC Urine Testing Market Analysis, 2023-2028 (in millions $ at the manufacturer’s level)
Regional Analysis
- Figure 13-1: POC Urine Testing Regional (US, Europe, Japan, Rest of World) Market Analysis, 2023 (%)
POC Urine Self-Testing
- Table 13-2: POC Urine Self-Testing Market Analysis, 2023-2028 (in millions $ at the manufacturer’s level)
POC Urine Test Professional Testing
- Table 13-3: POC Urine Professional Testing Market Analysis, 2023-2028 (in millions $ at the manufacturer’s level)
Competitive Analysis
- Table 13-4: Global POC Urine Testing Market, Revenues and Market Share of Leading Suppliers, 2023 (in millions $)
- Figure 13-2: Global POC Urine Strip Testing Manufacturers, by Percent, 2023 (%)
Chapter 14: Miscellaneous POC Testing
Microbiology
TSH
Allergy
Autoimmune
Others
Market Size and Growth
- Table 14-1: Global Miscellaneous POC Testing Market Analysis, 2023-2028 (in millions $ at the manufacturer’s level)
- Table 14-2: Global POC Miscellaneous Sales, by Test Category, 2023-2028 (Microbiology, TSH, Allergy, Autoimmune, Others TOTAL; $ millions)
Regional Analysis
- Figure 14-1: POC Miscellaneous Testing Regional (US, Europe, Japan, Rest of World) Market Analysis, 2023 (%)
Chapter 15: Issues and Trends
Overview
Wearables
- Table 15-1: Selected Wearable Devices
Mobile Healthcare Technologies
Telehealth
Telehealth eMed to Implement Home Test to Treat Program
Patient-centered Healthcare
Breath Test Advances
- Table 15-2: Selected Disease Markers in Exhaled Breath
Regulatory Hurdles
Reimbursement Challenges
PAMA
Competition
POC and Molecular Diagnostics
- Table 15-3: Selected Market Available Molecular POC Diagnostic Platforms
POC Biosensors and Microfluidics
- Table 15-4: Selected FDA-Approved Microfluidic-based POC Tests 2023
- Table 15-5: Selected Biochip and Biosensor Players, 2023
China as a POC Market
Emerging POC Technologies
POC Connectivity
COVID-19 Impact
Multiplexed POC Testing
- Figure 15-1: Multiplexed POC Testing Schematic
The Emergence of Non-invasive Technologies
Saliva and Swab
Optical Techniques
Near-infrared Scanning
Volatolomics
POC and Antibiotic Resistance Concern
Artificial Intelligence in POC
POC Future in Infectious Disease Diagnostics
Supply Chain Delays
Insurance Coverage for OTC Diagnostic Tests
Stand-Alone Emergency Department/Urgent Care Centers Combine with POC Team in New Mexico
Digital Diagnostics
Microfluidics and POC
Chapter 16: Total Global POC Testing Market and Competitor Analysis
Market Overview
- Table 16-1: Global POC Test Market, 2023-2028 (in millions $ at manufacturer level)
Market Analysis by Product Categories
- Table 16-2: Global POC Testing Market Analysis, by Product Category, 2023 (in millions $)
Market Analysis by Subcategory
POC Self-Testing
- Table 16-3: Global POC Self-Testing Market Analysis, by Product Category, 2023 (in millions $)
- Figure 16-1: Global POC Self-Testing Market Analysis, by Product Category, 2023 (%)
POC Professional Testing
- Table 16-4: Global POC Professional Testing Market Analysis, by Product Subcategory, 2023 (in millions $)
- Figure 16-2 : Global POC Professional Testing Market Analysis, by Product Subcategory, 2023 (%)
POC Testing by End-Use
- Figure 16-3: POC Testing, by End-user, 2023
Market by Device Technology
- Figure 16-4: Global POC Market, by Technology, by Sales, 2023, (%)
Market Analysis by Country
United States
- Table 16-5: US POC Testing Market Analysis, 2023-2028 (in millions $ at the manufacturer’s level)
Europe
- Table 16-6: Europe POC Testing Market Analysis, 2023-2028 (in millions $ at the manufacturer’s level)
- Germany
- France
- UK
- Switzerland and Sweden
- Other
- Figure 16-5: Europe POC Testing Percentage Participation, by Country, 2023 (%)
Japan
- Table 16-7: Japan POC Testing Market Analysis, 2023-2028 (in millions $ at the manufacturer’s level)
Rest of World
- Latin America
- China
- India
- South Korea
- Other RoW Countries
- Table 16-8: Global POC Testing Market Analysis, by Rest of World Region/Country, 2023 (in millions $)
- Figure 16-6: Global POC Testing Market Analysis, by Rest of World Region/Country, 2023 (%)
- Table 16-9: Global POC Testing Analysis, by Region/Country, 2023 (in millions $)
- Figure 16-7: Global POC Testing Market Analysis Percent, by Region/Country, 2023 (%)
Competitive Analysis
- Table 16-10: Global Top 10 POC Testing Market Revenues and Market Share of Leading Suppliers, 2023 (in millions $)
- Figure 16-8: Global POC Testing Market Share, by Leading Suppliers, 2023 (%)
Chapter 17: Corporate Profiles
Overview
1 Step Detect Associates, LLC
- Table 17-1: 1-Step Detect Associates Corporate Summary
Company Overview
Products
Abbott Laboratories
- Table 17-2: Abbott Corporate Summary
Company Overview
Products
COVID-19
Performance Review
- Table 17-3: Abbott Revenues 2020-2023 (in millions $)
Abingdon Health Ltd.
- Table 17-4: Abingdon Health Corporate Summary
Company Overview
Products
COVID-19
Access Bio, Inc.
- Table 17-5: Access Bio Corporate Summary
Company Overview
Products
COVID-19
AccuBioTech Co, Ltd.
- Table 17-6: AccuBioTech Corporate Summary
Company Overview
Products
COVID-19
ACON Laboratories, Inc
- Table 17-7: ACON Laboratories Corporate Summary
Company Overview
Products
COVID-19
Aerscher Diagnostics, LLC
- Table 17-8: Aerscher Diagnostics Corporate Summary
Company Overview
Products
Alfa Scientific Designs, Inc
- Table 17-9: Alfa Scientific Corporate Summary
Company Overview
Products
COVID-19
American Bio Medica Corporation
- Table 17-10: American Bio Medica Corporate Summary
Company Overview
Products
COVID-19
ARKRAY, Inc.
- Table 17-11: ARKRAY Corporate Summary
Company Overview
Products
Artron Laboratories, Inc
- Table 17-12: Artron Laboratories Corporate Summary
Company Overview
Products
COVID-19
Ascensia Diabetes Care Holdings AG
- Table 17-13: Ascensia Diabetes Care Corporate Summary
Company Overview
Products
Atlas Link Biotech Co., Ltd
- Table 17-14: Atlas Link Biotech Corporate Summary
Company Overview
Products
COVID-19
Autobio Diagnostics Co., Ltd
- Table 17-15: Autobio Diagnostics Corporate Summary
Company Overview
Products
COVID-19
Beckman Coulter, Inc
- Table 17-16: Beckman Coulter Corporate Summary
Company Overview
Products
COVID-19
Company Financials
- Table 17-17: Beckman Coulter Revenue, 2020-2023 ($ millions)
Becton Dickinson (BD)
- Table 17-18: BD Corporate Summary
Company Overview
Products
COVID-19
Company Financials
- Table 17-19: BD Corporation Revenues, 2020-2023 ($ millions)
Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.
- Table 17-20: Beijing Wantai Biological Pharmacy Enterprise Corporate Summary
Company Overview
Products
COVID-19
Bhat Bio-Tech India Private Ltd. (BBI)
- Table 17-21: Bhat Bio-Tech India Private Corporate Summary
Company Overview
Products
COVID-19
binx health
- Table 17-22: binx health Corporate Summary
Company Overview
Products
COVID-19
bioLytical Laboratories
- Table 17-23: bioLytical Laboratories Corporate Summary
Company Overview
Products
COVID-19
BioMedomics, Inc
- Table 17-24: BioMedomics Corporate Summary
Company Overview
Products
COVID-19
Biomeme, Inc
- Table 17-25: Biomeme Corporate Summary
Company Overview
Products
Biomerica, Inc.
- Table 17-26: Biomerica Corporate Summary
Company Overview
Products
Company Financials
- Table 17-27: Biomerica Corporation Revenues, 2020-2023 ($ millions)
bioMérieux SA
- Table 17-28: bioMérieux SA Corporate Summary
Company Overview
Products
COVID-19
Company Financials
- Table 17-29: bioMérieux Revenues, 2020-2023 ($ millions)
Bio-Rad Laboratories Inc.
- Table 17-30: Bio-Rad Labs Corporate Summary
Company Overview
Products
Company Financials
- Table 17-31: Bio-Rad Corporation Revenues, 2020-2023 ($ millions)
Biosynex SA
- Table 17-32: Biosynex SA Corporate Summary
Company Overview
Products
Biotron Diagnostics, Inc.
- Table 17-33: Biotron Diagnostics Corporate Summary
Company Overview
Products
Boditech Med Inc
- Table 17-34: Boditech Med Corporate Summary
Company Overview
Products
COVID-19
Boson Biotech Co. Ltd
- Table 17-35: Boson Biotech Corporate Summary
Company Overview
Products
COVID-19
BTNX Inc.
- Table 17-36: BTNX Corporate Summary
Company Overview
Products
COVID-19
Cepheid, Inc
- Table 17-37: Cephid Corporate Summary
Company Overview
Products
COVID-19
Performance Review
- Table 17-38: Cepheid Revenues, 2020-2023 ($ millions)
Chembio Diagnostics Systems, Inc.
- Table 17-39: Chembio Diagnostic Corporate Summary
Company Overview
Products
COVID-19
Church & Dwight Co. Inc
- Table 17-40: Church & Dwight Corporate Summary
Company Overview
Products
Performance Review
- Table 17-41: Church and Dwight Revenues, 2020-2023 ($ millions)
Clarity Diagnostics, LLC
- Table 17-42: Clarity Diagnostics Corporate Summary
Company Overview
Products
COVID-19
Confirm Biosciences
- Table 17-43: Confirm Biosciences Corporate Summary
Company Overview
Products
COVID-19
CTK Biotech, Inc.
- Table 17-44: CTK Biotech Corporate Summary
Company Overview
Products
COVID-19
Cue Health
- Table 17-45: Cue Health Corporate Summary
Company Overview
Products
COVID-19
Danaher Corporation
- Table 17-46: Danaher Corporation Summary
Company Overview
Products
Dexcom, Inc
- Table 17-47: Dexcom Corporate Summary
Company Overview
Products
Performance Review
- Table 17-48: Dexcom Revenues, 2020-2023 ($ millions)
DIALAB GmbH
- Table 17-49: DIALAB Corporate Summary
Company Overview
Products
COVID-19
DiaSys Diagnostic Systems GmbH (Mindray)
- Table 17-50: DiaSys Diagnostic Systems Corporate Summary
Company Overview
Products
COVID-19
Diazyme Laboratories, Inc.
- Table 17-51: Diazyme Laboratories Corporate Summary
Company Overview
Products
COVID-19
DNA Electronics Ltd. (DNAe)
- Table 17-52: DNA Electronics Corporate Summary
Company Overview
Products
Dr. Fooke-Achterrath Laboratorien GmbH
- Table 17-53: Dr. Fooke-Achterrath Laboratorien Corporate Summary
Company Overview
Products
COVID-19
DxGen Corp.
- Table 17-54: DxGen Corporate Summary
Company Overview
Products
COVID-19
Eiken Chemical Co Ltd.
- Table 17-55: Eiken Chemical Corporate Summary
Company Overview
Products
COVID-19
Performance Review
- Table 17-56: Eiken Chemical Revenues, 2020-2023 ($ millions)
EKF Diagnostics Holdings plc
- Table 17-57: EKF Diagnostics Corporate Summary
Company Overview
Products
ELITechGroup S.A.S.
- Table 17-58: ELITechGroup Corporate Summary
Company Overview
Products
COVID-19
Eurobio Scientific
- Table 17-59: Eurobio Scientific Corporate Summary
Company Overview
Products
COVID-19
Everlywell
- Table 17-60: Everlywell Corporate Summary
Company Overview
Products
COVID-19
Exact Sciences
- Table 17-61: Exact Sciences Corporate Summary
Company Overview
Products
Performance Review
- Table 17-62: Exact Sciences Revenues, 2020-2023 ($ millions)
EY Laboratories
- Table 17-63: EY Laboratories Corporate Summary
Company Overview
Products
First Check Diagnostics LLC
- Table 17-64: First Check Diagnostics Corporate Summary
Company Overview
Products
GenBio
- Table 17-65: GenBio Corporate Summary
Company Overview
Products
Genedrive plc
- Table 17-66: Genedrive Corporate Summary
Company Overview
Products
COVID-19
Performance Review
- Table 17-67: Genedrive Revenues, 2020-2023 ($ millions)
GeTein Biotech Inc.
- Table 17-68: GeTein Corporate Summary
Company Overview
Products
COVID-19
Helena Laboratories
- Table 17-69: Helena Laboratories Corporate Summary
Company Overview
Products
Hemosure, Inc. (W.H.P.M)
- Table 17-70: Hemosure Corporate Summary
Company Overview
Products
HORIBA, Ltd.
- Table 17-71: HORIBA Corporate Summary
Company Overview
Products
Performance Review
- Table 17-72: HORIBA Revenues, 2020-2023 ($ millions)
Immune IQ
- Table 17-73: Immune IQ Corporate Summary
Company Overview
Products
Immunosciences Lab, Inc.
- Table 17-74: Immunosciences Lab Corporate Summary
Company Overview
Products
Immunostics, Inc
- Table 17-75: Immunostics Corporate Summary
Company Overview
Products
COVID-19
JAL Innovation PTE LTD
- Table 17-76: JAL Innovation Corporate Summary
Company Overview
Products
Jant Pharmacal Corporation
- Table 17-77: Jant Pharmacal Corporate Summary
Company Overview
Products
- Mitra & Co Pvt. Ltd
- Table 17-78: J Mitra Corporate Summary
Company Overview
Products
Covid-19
Kypha
- Table 17-79: Kypha Corporate Summary
Company Overview
Products
LamdaGen Corporation
- Table 17-80: LamdaGen Corporate Summary
Company Overview
Products
COVID-19
LifeScan, Inc
- Table 17-81: LifeScan Corporate Summary
Company Overview
Products
LifeSign, LLC
- Table 17-82: LifeSign Corporate Summary
Company Overview
Products
COVID-19
LightDeck Diagnostics
- Table 17-83: LightDeck Diagnostics Corporate Summary
Company Overview
Products
COVID-19
LumiraDx UK Limited
- Table 17-84: LumiraDx Corporate Summary
Company Overview
Products
Macherey-Nagel GmbH & Co. KG
- Table 17-85: Macherey-Nagel Corporate Summary
Company Overview
Products
Medix Biochemica
- Table 17-86: Medix Biochemica Corporate Summary
Company Overview
Products
COVID-19
MedMira, Inc
- Table 17-87: MedMira Corporate Summary
Company Overview
Products
COVID-19
Performance Review
- Table 17-88: MedMira Revenues, 2020-2023 ($ thousands)
Medtronic, Inc.
- Table 17-89: Medtronic Corporate Summary
Company Overview
Products
Performance Review
- Table 17-90: Medtronic Revenues, 2020-2023 ($ millions)
- Menarini Diagnostics srl.
- Table 17-91: Menarini Diagnostics Corporate Summary
Company Overview
Products
COVID-19
Meridian Bioscience, Inc
- Table 17-92: Meridian Bioscience Corporate Summary
Company Overview
Products
COVID-19
MiCo BioMed
- Table 17-93: MiCo BioMed Summary
Company Overview
Products
Nano-Ditech Corporation
- Table 17-94: Nano-Ditech Corporate Summary
Company Overview
Products
COVID-19
Nexus Dx Inc
- Table 17-95: Nexus Dx Corporate Summary
Company Overview
Products
NG Biotech
- Table 17-96: NG Biotech Corporate Summary
Company Overview
Products
COVID-19
Noble Medical, Inc
- Table 17-97: Noble Medical Corporate Summary
Company Overview
Products
Nova Biomedical Corp.
- Table 17-98: Nova Biomedical Corporate Summary
Company Overview
Products
Oasis Diagnostics Corporation
- Table 17-99: Oasis Diagnostics Corporate Summary
Company Overview
Products
Operon S.A.
- Table 17-100: Operon Corporate Summary
Company Overview
Products
COVID-19
OPKO Health, Inc
- Table 17-101: OPKO Health Corporate Summary
Company Overview
Products
COVID-19
Performance Review
- Table 17-102: OPKO Health Revenues, 2020-2023 ($ millions)
OraSure Technologies, Inc.
- Table 17-103: OraSure Technologies Corporate Summary
Company Overview
Products
COVID-19
Performance Review
- Table 17-104: OraSure Revenues, 2020-2023 ($ millions)
PixCell Medical Technologies
- Table 17-105: PixCell Corporate Summary
Company Overview
Products
Polymedco, Inc
- Table 17-106: Polymedco Corporate Summary
Company Overview
Products
Polymer Technologies, Inc (PTS Diagnostics)
- Table 17-107: Polymer Technologies Corporate Summary
Company Overview
Products
COVID-19
Preventis GmbH
- Table 17-108: Preventis Corporate Summary
Company Overview
Products
Princeton Biomeditech Corporation
- Table 17-109: Princeton Biomeditech Corporate Summary
Company Overview
Products
Covid-19
QuantuMDx Group Limited
- Table 17-110: QuantuMDx Group Corporate Summary
Company Overview
Products
COVID-19
QuidelOrtho Corporation
- Table 17-111: QuidelOrtho Corporate Summary
Company Overview
Products
COVID-19
Performance Review
- Table 17-112: QuidelOrtho Revenues, 2020-2023 ($ millions)
Radiometer Medical A/S
- Table 17-113: Radiometer Medical Corporate Summary
Company Overview
Products
Performance Review
- Table 17-114: Radiometer, 2020-2023 ($ millions)
Randox Laboratories Limited
- Table 17-115: Randox Labs Corporate Summary
Company Overview
Products
COVID-19
Response Biomedical Corp
- Table 17-116: Response Biomedical Corporate Summary
Company Overview
Products
COVID-19
Reszon Diagnostics International Sdn. Bhd.
- Table 17-117: Reszon Diagnostics Corporate Summary
Company Overview
Products
COVID-19
Rheonix, Inc
- Table 17-118: Rheonix Corporate Summary
Company Overview
Products
COVID-19
Roche Diagnostic Corporation
- Table 17-119: Roche Diagnostic Corporate Summary
Company Overview
Products
- Table 17-120: Roche POC Marketed Products
COVID-19
Performance Review
- Table 17-121: Roche Diagnostics, 2020-2023 ($ millions)
Savyon Diagnostics
- Table 17-122: Savyon Diagnostics Corporate Summary
Company Overview
Products
COVID-19
Sekisui Diagnostics LLC
- Table 17-123: Sekisui Diagnostics Corporate Summary
Company Overview
Products
COVID-19
Siemens Healthineers GmbH
- Table 17-124: Siemens Healthineers Corporate Summary
Company Overview
Products
COVID-19
Performance Review
- Table 17-125: Siemens Healthineers, 2020-2023 ($ millions)
Sysmex Corporation
- Table 17-126: Sysmex Corporate Summary
Company Overview
Products
Performance Review
- Table 17-127: Sysmex, 2020-2023 ($ millions)
TECHLAB, Inc.
- Table 17-128: TECHLAB Corporate Summary
Company Overview
Products
Trinity Biotech PLC
- Table 17-129: Trinity Biotech Corporate Summary
Company Overview
Products
COVID-19
Performance Review
- Table 17-130: Trinity Biotech Revenues, 2020-2023 ($ millions)
Trividia Health
- Table 17-131: Trividia Health Corporate Summary
Company Overview
Products
Tulip Diagnostics Ltd (Tulip Group)
- Table 17-132: Tulip Diagnostics Corporate Summary
Company Overview
Product
COVID-19
VedaLab
- Table 17-133: VedaLab Corporate Summary
Company Overview
Products
COVID-19
Werfen
- Table 17-136: Werfen Corporate Summary
Company Overview
Products
Performance Review
- Table 17-137: Werfen, 2020-2023 ($ millions)
